1 hour ago
COMPASS Pathways (CMPS) Stock Soars 25% on Trump’s Psychedelics Research Order
COMPASS Pathways (CMPS) stock jumped 25% after Trump's executive order on psychedelic research. Positive Phase 3 data boosts investor confidence.
The post COMPASS Pathways (CMPS) Stock Soars 25% on Trump’s Psychedelics Research Order appeared first on Blockonomi.
Source: Blockonomi →Related News
- 48 minutes ago
Northrop Grumman (NOC) Q1 Earnings Preview: Margin Expansion Takes Center Stage...
- 54 minutes ago
Marvell Technology (MRVL) Stock: Custom AI Chips and Google Partnership Drive Gr...
- 1 hour ago
OpenAI Prepares to Challenge Google With Advanced AI Image Generator
- 1 hour ago
Evercore ISI Flags Arista Networks (ANET) and IBM (IBM) Stock as Q1 Earnings Win...
- 1 hour ago
Amazon (AMZN) Stock: Anthropic’s Explosive Growth Could Fuel AWS Ahead of Earnin...